DE3877647T2 - Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung. - Google Patents

Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung.

Info

Publication number
DE3877647T2
DE3877647T2 DE8888810502T DE3877647T DE3877647T2 DE 3877647 T2 DE3877647 T2 DE 3877647T2 DE 8888810502 T DE8888810502 T DE 8888810502T DE 3877647 T DE3877647 T DE 3877647T DE 3877647 T2 DE3877647 T2 DE 3877647T2
Authority
DE
Germany
Prior art keywords
composition
production
physiologically effective
effective products
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888810502T
Other languages
English (en)
Other versions
DE3877647D1 (de
Inventor
Yoji Institute Of Bi Shibayama
Yoshio Institute Of B Toyomaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Publication of DE3877647D1 publication Critical patent/DE3877647D1/de
Application granted granted Critical
Publication of DE3877647T2 publication Critical patent/DE3877647T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8888810502T 1987-07-23 1988-07-21 Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung. Expired - Fee Related DE3877647T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62184981A JP2651674B2 (ja) 1987-07-23 1987-07-23 新規生理活性物質及びその製造方法

Publications (2)

Publication Number Publication Date
DE3877647D1 DE3877647D1 (de) 1993-03-04
DE3877647T2 true DE3877647T2 (de) 1993-05-13

Family

ID=16162710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888810502T Expired - Fee Related DE3877647T2 (de) 1987-07-23 1988-07-21 Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung.

Country Status (6)

Country Link
US (1) US5057324A (de)
EP (1) EP0300973B1 (de)
JP (1) JP2651674B2 (de)
AT (1) ATE84721T1 (de)
DE (1) DE3877647T2 (de)
ES (1) ES2045182T3 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2539674B2 (ja) * 1987-11-06 1996-10-02 日本臓器製薬株式会社 新規生理活性物質
US4985254A (en) * 1987-11-06 1991-01-15 Nippon Zoki Pharmaceutical Co., Ltd. Method of treating ischemic diseases
EP0341209B1 (de) * 1988-04-30 1993-09-15 Nippon Zoki Pharmaceutical Co. Ltd. Physiologisch wirkende Substanzen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen davon
JP2588109B2 (ja) * 1993-03-19 1997-03-05 日本臓器製薬株式会社 鎮痛剤
JP3213832B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定法
JP3213831B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定方法
JP2594222B2 (ja) * 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−ｋｆ
JP4033936B2 (ja) * 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
AU721804B2 (en) * 1997-01-08 2000-07-13 Nippon Zoki Pharmaceutical Co., Ltd. Nitrogen monoxide production suppressor
JPH1180005A (ja) * 1997-09-12 1999-03-23 Nippon Zoki Pharmaceut Co Ltd 骨粗鬆症治療剤
KR19990044835A (ko) 1997-11-28 1999-06-25 고니시 진우에몬 생약추출물
CN100425692C (zh) * 1998-06-02 2008-10-15 株式会社富吉摩托普拉泽兹 含有高质量生理活性的家兔发痘组织的制造方法
KR20010020741A (ko) 1999-04-15 2001-03-15 고니시 진우에몬 신규의 생체 활성화 물질
US6726932B2 (en) 2000-02-18 2004-04-27 Nippon Zoki Pharmaceutical Co., Ltd. Fatty acid-containing composition
US6913900B2 (en) * 2001-08-29 2005-07-05 Nippon Zoki Pharmaceutical Co., Ltd. Plasma prekallikrein activation and kallikrein production assay
CN1207005C (zh) * 2002-10-31 2005-06-22 威世药业（如皋）有限公司 含生物活性物质的兔皮和其用途
JP3887731B2 (ja) * 2002-10-31 2007-02-28 日本臓器製薬株式会社 線維筋痛症治療剤
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) * 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
AU2011316756B2 (en) 2010-10-14 2015-01-22 Nippon Zoki Pharmaceutical Co., Ltd A method for promoting the synthesis of collagen and proteoglycan in chondrocytes
WO2014178394A1 (ja) 2013-04-30 2014-11-06 日本臓器製薬株式会社 抽出物及び該抽出物を含有する製剤
CN105663166B (zh) * 2016-03-02 2020-04-17 中国人民解放军疾病预防控制所 特异性抗天花病毒感染模型毒株的生物活性制剂及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53101515A (en) * 1977-02-17 1978-09-05 Nippon Zoki Pharmaceutical Co Medicine having anodyne * sedative and antiallergic activity and production thereof
JPS54130502A (en) * 1978-03-31 1979-10-09 Nippon Zoki Pharmaceutical Co Physiological active substance*its manufacture and medical composition
JPS5528943A (en) * 1978-08-22 1980-02-29 Nippon Zoki Pharmaceut Co Ltd Medicinal composition
JPS5587724A (en) * 1978-12-27 1980-07-02 Nippon Zoki Pharmaceut Co Ltd Selective immune enhancer
JPS5775991A (en) * 1980-10-27 1982-05-12 Nippon Zoki Pharmaceut Co Ltd Novel physiologically active substance jcv-80
JPS5777697A (en) * 1980-11-04 1982-05-15 Nippon Zoki Pharmaceut Co Ltd Physiologically active substance nsq
JPS5835117A (ja) * 1981-08-25 1983-03-01 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質ｎｓｈ
JPS59118711A (ja) * 1982-12-25 1984-07-09 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質

Also Published As

Publication number Publication date
ES2045182T3 (es) 1994-01-16
EP0300973A1 (de) 1989-01-25
US5057324A (en) 1991-10-15
DE3877647D1 (de) 1993-03-04
JPS6429389A (en) 1989-01-31
EP0300973B1 (de) 1993-01-20
ATE84721T1 (de) 1993-02-15
JP2651674B2 (ja) 1997-09-10

Similar Documents

Publication Publication Date Title
DE3877647D1 (de) Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung.
RU2159761C2 (ru) Замещенные 4-биарилмасляные или 5-биарилпентановые кислоты или их производные, способы их получения, фармацевтическая композиция и способ лечения
DE3876877T2 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE59310327D1 (de) Verwendung von Komplement-Inhibitoren zur Herstellung eines Arzneimittels zur Prophylaxe und Therapie von entzündlichen Darm- und Hauterkrankungen sowie Purpura
DE69706566D1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
DE69113386T2 (de) Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
DE3688038T2 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
DE59309649D1 (de) Substituierte Cyclohexan-Derivate zur Behandlung von Krankheiten
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ATE94401T1 (de) Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon.
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
DE3581416D1 (de) Arzneimittel und die verwendung schwerloeslicher calcium- und/oder magnesiumverbindungen zur herstellung eines arzneimittels.
EP0328924A3 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE143809T1 (de) Placentaextrakt und verfahren zu seiner herstellung
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
WO2001014576A3 (en) Process and intermediates for the preparation of isoxazolecaroxamides and analogues
DE3769358D1 (de) 1-acyl-2,3-dihydro-4(1h)-chinolinon-4-oxim-derivate, verfahren zur herstellung davon, pharmazeutische zusammensetzungen und zwischenprodukte.
DE68916777D1 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
DE69610045D1 (de) Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen
DE3888697D1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
ATE218561T1 (de) Terpenoide lactonverbindungen und verfahren zu ihrer herstellung
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
ATE201993T1 (de) Verwendung von olanzapine zur herstellung eines arzneimittels zur behandlung der zerebralen fokalen ischämie
DE3887174T2 (de) Verfahren zur Herstellung von 2,3-Dihydro-1H-imidazolylalkoxyinden-Derivaten und ihren pharmazeutisch annehmbaren Salzen, und Zwischenprodukte hierfür.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee